NIOX Group (LON:NIOX) Shares Down 0.8% – Here’s What Happened

NIOX Group Plc (LON:NIOX)’s stock price fell 0.8% during mid-day trading on Thursday . The company traded as low as GBX 69.40 and last traded at GBX 70.40. 1,173,229 shares traded hands during mid-day trading, an increase of 15% from the average session volume of 1,021,858 shares. The stock had previously closed at GBX 71.

NIOX Group Trading Down 1.0%

The firm has a 50-day moving average of GBX 71.65 and a 200 day moving average of GBX 69.42. The company has a market cap of £291.31 million, a P/E ratio of 55.77 and a beta of 0.92. The company has a current ratio of 6.31, a quick ratio of 1.94 and a debt-to-equity ratio of 1.10.

NIOX Group (LON:NIOX) last issued its earnings results on Tuesday, September 30th. The company reported GBX 1.43 earnings per share for the quarter. NIOX Group had a return on equity of 13.29% and a net margin of 28.21%. On average, analysts predict that NIOX Group Plc will post 1.1658256 earnings per share for the current fiscal year.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.